These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31892977)

  • 41. Giant primary mesenteric liposarcoma: a rare case report.
    Khan N; Afroz N; Fatima U; Raza MH; Rab AZ
    Indian J Pathol Microbiol; 2007 Oct; 50(4):787-9. PubMed ID: 18306555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Relationship between expression of c-myc and p53 in liposarcoma].
    Wang YL; Qiu JS; Xiong M
    Ai Zheng; 2002 Jan; 21(1):63-7. PubMed ID: 12500400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soft tissue tumours: the impact of cytogenetics and molecular genetics.
    Fletcher CD
    Verh Dtsch Ges Pathol; 1997; 81():318-26. PubMed ID: 9474886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraperitoneal dedifferentiated liposarcoma: a case report.
    Karaman A; Kabalar ME; Ozcan O; Koca T; Binici DN
    World J Gastroenterol; 2008 Oct; 14(38):5927-9. PubMed ID: 18855997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis.
    Meis-Kindblom JM; Sjögren H; Kindblom LG; Peydró-Mellquist A; Röijer E; Aman P; Stenman G
    Virchows Arch; 2001 Aug; 439(2):141-51. PubMed ID: 11561754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caveolin-1, Caveolin-2 and Cavin-1 are strong predictors of adipogenic differentiation in human tumors and cell lines of liposarcoma.
    Codenotti S; Vezzoli M; Poliani PL; Cominelli M; Bono F; Kabbout H; Faggi F; Chiarelli N; Colombi M; Zanella I; Biasiotto G; Montanelli A; Caimi L; Monti E; Fanzani A
    Eur J Cell Biol; 2016 Aug; 95(8):252-64. PubMed ID: 27168348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.
    Keung EZ; Lazar AJ; Torres KE; Wang WL; Cormier JN; Ashleigh Guadagnolo B; Bishop AJ; Lin H; Hunt KK; Bird J; Lewis VO; Patel SR; Wargo JA; Somaiah N; Roland CL
    BMC Cancer; 2018 Sep; 18(1):913. PubMed ID: 30249211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrative Genomic Analyses Yield Cell-Cycle Regulatory Programs with Prognostic Value.
    Cheng C; Lou S; Andrews EH; Ung MH; Varn FS
    Mol Cancer Res; 2016 Apr; 14(4):332-43. PubMed ID: 26856934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soft tissue liposarcoma: histological subtypes, MRI and CT findings.
    Barile A; Zugaro L; Catalucci A; Caulo M; Di Cesare E; Splendiani A; Gallucci M; Masciocchi C
    Radiol Med; 2002 Sep; 104(3):140-9. PubMed ID: 12471362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fat-specific FUS-DDIT3-transgenic mice establish PPARgamma inactivation is required to liposarcoma development.
    Pérez-Mancera PA; Vicente-Dueñas C; González-Herrero I; Sánchez-Martín M; Flores-Corral T; Sánchez-García I
    Carcinogenesis; 2007 Oct; 28(10):2069-73. PubMed ID: 17468515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical management of spinal liposarcoma: a case series of 7 patients and literature review.
    Zhao C; Han Z; Xiao H; Yang C; Zhao Y; Fan T; Sun Z; Liu T; Xiao J
    Eur Spine J; 2016 Dec; 25(12):4088-4093. PubMed ID: 26781842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Syndecan-1 regulates adipogenesis: new insights in dedifferentiated liposarcoma tumorigenesis.
    Zaragosi LE; Dadone B; Michiels JF; Marty M; Pedeutour F; Dani C; Bianchini L
    Carcinogenesis; 2015 Jan; 36(1):32-40. PubMed ID: 25344834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pleomorphic Liposarcoma Arising in a Lipoleiomyosarcoma of the Uterus: Report of a Case With Genetic Profiling by a Next Generation Sequencing Panel.
    Schoolmeester JK; Stamatakos MD; Moyer AM; Park KJ; Fairbairn M; Fader AN
    Int J Gynecol Pathol; 2016 Jul; 35(4):321-6. PubMed ID: 26598981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/round-cell liposarcomas.
    Schneider-Stock R; Jaeger V; Rys J; Epplen JT; Roessner A
    Int J Cancer; 2000 Jan; 89(1):63-8. PubMed ID: 10719732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological therapies for Liposarcoma.
    Saponara M; Stacchiotti S; Gronchi A
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):361-377. PubMed ID: 28135854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of molecular biology to individualize therapy for patients with liposarcoma.
    Abbas Manji G; Singer S; Koff A; Schwartz GK
    Am Soc Clin Oncol Educ Book; 2015; ():213-8. PubMed ID: 25993159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Lipomatous tumors of the skin and soft tissue. New entities and concepts].
    Mentzel T
    Pathologe; 2000 Nov; 21(6):441-8. PubMed ID: 11148824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice.
    Pérez-Mancera PA; Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Flores T; Battaner E; Gutiérrez-Adán A; Pintado B; Sánchez-García I
    Oncogene; 2002 Mar; 21(11):1679-84. PubMed ID: 11896599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary liposarcoma of the pancreas: A review illustrated by findings from a recent case.
    Machado MC; Fonseca GM; de Meirelles LR; Zacchi FF; Bezerra RO
    Pancreatology; 2016; 16(5):715-8. PubMed ID: 27423533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of glucagon receptors in human adipocytes from a liposarcoma.
    Carranza MC; Simón MA; Torres A; Romero B; Calle C
    J Endocrinol Invest; 1993 Jun; 16(6):439-42. PubMed ID: 8396602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.